Skip to content
10-Q

Quarterly Report

BIOSCIENCE HEALTH INNOVATIONS INC. BHIC

0001185185-24-000468

← back to feed
Filed
May 3, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 3, 2024 41.6M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 $92.94K
Cash And Equivalents Q1 2024 · Dec 31, 2023 $19.24K
Total Liabilities Q1 2024 · Mar 31, 2024 $39.94K
Total Liabilities Q1 2024 · Dec 31, 2023 $100.15K
Current Assets Q1 2024 · Mar 31, 2024 $154.8K
Current Assets Q1 2024 · Dec 31, 2023 $93.39K
Total Assets Q1 2024 · Mar 31, 2024 $154.8K
Total Assets Q1 2024 · Dec 31, 2023 $93.39K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$66.67K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$88.99K
Stockholders Equity Q1 2024 · Dec 31, 2022 −$17.18K
Sga Expense Q1 2024 · Mar 31, 2023 $92.31K
Net Income Q1 2024 · Mar 31, 2023 −$70.72K
Operating Income Q1 2024 · Mar 31, 2023 −$70.72K
Gross Profit Q1 2024 · Mar 31, 2023 $27.59K
Cost Of Revenue Q1 2024 · Mar 31, 2023 $4.75K
Revenue Q1 2024 · Mar 31, 2023 $32.34K